Quantcast

Latest Anti-diabetic drug Stories

2009-02-18 09:00:00

AUGUSTA, Ga., Feb. 18 /PRNewswire/ -- Taking Control of Your Diabetes (TCOYD) announced findings today from a recent survey conducted by national research firm Yankelovich that found that more than one in five Augustans with type 2 diabetes mistakenly think that excess weight has a positive effect on the disease. In fact, research shows that being overweight often contributes to the development of diabetes, complicates proper management of the disease and can lead to other serious...

2009-02-17 08:11:00

LONDON, Feb. 17 /PRNewswire-FirstCall/ -- GlaxoSmithKline today announced initiation and dosing of the first patient of the Phase III clinical trial programme to evaluate the efficacy, safety and tolerability of the investigational GLP-1 (Glucagon-like peptide 1) agonist Syncria(R) (albiglutide) in men and women with type 2 diabetes. The Phase III programme will include more than 4,000 patients. "Despite continued advances in diabetes treatment, this devastating disease continues to...

2009-01-26 04:57:00

DUBLIN, Ireland, January 26 /PRNewswire-FirstCall/ -- ICON plc, (NASDAQ: ICLR; ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the launch of a new electronic solution that will accelerate the adjudication of cardiovascular events in diabetes studies. The evaluation of cardiovascular risk in diabetic trials has been the subject of recent FDA guidance. Recommendations published...

2009-01-20 22:54:58

A Harvard researcher's discovery in a old German medical journal may provide a new, cost-effective way to help treat diabetes. Steven Shoelson found an 1876 article in the journal that suggested the arthritis drug salsalate may help diabetics control their blood sugar, The Wall Street Journal reported Tuesday. Shoelson and colleagues at the Joslin Diabetes Center have been testing the anti-inflammatory drug in several small studies of type 2 diabetes and found it significantly lowered spikes...

2009-01-08 14:10:00

LOS ALTOS, Calif., Jan. 8 /PRNewswire/ -- InteKrin Therapeutics, Inc., will present at the 27th Annual JP Morgan Global Healthcare Conference at 9:00 a.m. Pacific Time on Tuesday, January 13, 2009, to be held at the Westin St. Francis in San Francisco, California. InteKrin Therapeutics' President and CEO Denny Lanfear will present at the conference. About InteKrin (http://www.InteKrin.com): InteKrin Therapeutics is a privately-held clinical stage biopharmaceutical company...

cc1c1ca14df3534f405c12b9c5426a801
2008-12-29 13:19:58

A small study showed that obesity surgery could reverse diabetes in teens, just as it does in adults. The researchers reported that all but one of the 11 extremely obese teens studied saw their diabetes disappear within a year after weight-loss surgery. The 11th patient still had diabetes, but needed much less insulin and stopped taking diabetes pills. Studies in the past have shown the diabetes benefits of obesity surgery for adults. Dr. Thomas Inge, a pediatric surgeon at Cincinnati...

17e9e23eb4525bc0338a2f54d9c65e4a1
2008-12-18 08:40:06

Twenty-three million Americans suffer from Type 2 diabetes, and the FDA says it will now strictly screen the drugs created to treat the epidemic. Some believe the Food and Drug Administration's policy change will provide greater assurance of safety to doctors and patients, but it will make it more costly and time-consuming for companies to develop drugs that lower blood sugars. "I think the FDA got this one right," said Dr. Steven Nissen, a Cleveland Clinic cardiologist who raised the...

2008-12-17 14:44:27

The U.S. Food and Drug Administration is recommending companies developing type 2 diabetes drugs and biologics evaluate the products' cardiovascular risks. The FDA said pharmaceutical companies should provide evidence the therapy will not increase the risk of such cardiovascular events as a heart attack. The recommendation applies to all diabetes drugs currently under development. We need to better understand the safety of new anti-diabetic drugs. Therefore, companies should conduct a more...

2008-10-31 18:00:00

HARRISBURG, Pa., Oct. 31 /PRNewswire-USNewswire/ -- November is American Diabetes Month and acting Secretary of Health Everette James today reminded Pennsylvanians that there are steps they can take to reduce the risk of becoming diabetic. "Diabetes rates continue to rise, making the disease a serious -- and expensive -- health problem in Pennsylvania," said James. "Studies show many cases of diabetes can be delayed or prevented if people adopt some basic healthy behaviors. We want every...

2008-10-06 12:00:12

VIVUS, Inc. (NASDAQ: VVUS), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced the weight loss effects of Qnexa in subjects with type 2 diabetes at The Obesity Society Annual Scientific Meeting in Phoenix, Arizona. Dr. Barbara Troupin, Senior Director of Clinical Development, announced the data in a poster presentation titled "The Weight Loss Effects of VI-0521 in Type 2 Diabetes." On an intent-to-treat basis, subjects...


Word of the Day
attercop
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'
Related